Karen Andersen, CFA, strategist covering the biopharma industry for Morningstar, Inc., Chicago, which tracks 620,000 investment offerings. Morningstar.com
Featured Expert: Karen Andersen, CFA| January 20, 2024
Many of the pandemic’s stock darlings have crashed, and they won’t rebound anytime soon because consumer habits have shifted. But if you dig deeper, you...
